SA
GSK icon

Seneschal Advisors’s GSK GSK Stock Holding History

Seneschal Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-148
Closed -$8.17K – 607
2026
Q1 		$8.17K Hold
148
– – 0.01% 153
2025
Q4 		$7.26K Hold
148
– – 0.01% 153
2025
Q3 		$6.39K Buy
+148
New +$5.78K ﹤0.01% 166

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Seneschal Advisors's GSK Position: Q2 2026 in Review

Seneschal Advisors sold out of GSK (GSK) in Q2 2026, closing a stake of 148 shares — an estimated $8.17K sold.

Seneschal Advisors first reported a position in GSK in Q3 2025 and held it in 3 quarters. The position peaked at $8.17K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Seneschal Advisors reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Seneschal Advisors sold 148 GSK shares in Q2 2026, an estimated $8.17K.
  • Seneschal Advisors first reported a position in GSK in Q3 2025 and held it in 3 quarters.
  • Seneschal Advisors's GSK position peaked at $8.17K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.